Reporting of Patient Global Assessments in Atopic Dermatitis Randomized Controlled Trials

Abstract

Get full access to this article

View all access options for this article.

References

Chan

, Tetzlaff

, Gøtzsche

, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ, 2013; 346:e7586.

Mokkink

, Terwee

, Patrick

, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res, 2010; 19(4):539–549.

Moher

, Hopewell

, Schulz

, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg, 2012; 10(1):28–55.

Schmitt

, Langan

, Stamm

, et al. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol, 2011; 131(3):623–630.

Chalmers

, Thomas

, Apfelbacher

, et al. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol, 2018; 178(5):e332–e341.